Showing results (171-180 of 2,880) with videos related to
Sort By:
Pageof 288
European Heart Journal. Cardiovascular Pharmacotherapy|February 26, 2020
Obesity and atrial fibrillation: making inroads through fatSaad Javed, Dhiraj Gupta, Gregory Y H LipCurrent Opinion in Investigational Drugs (London, England : 2000)|April 6, 2007
Drug evaluation: rivaroxaban, an oral, direct inhibitor of activated factor XPuneet Kakar, Timothy Watson, Gregory Y H LipClinical Medicine (London, England)|March 14, 2007
Modern management of atrial fibrillationTimothy Watson, Eduard Shanstila, Gregory Y H LipEuropean Heart Journal|January 29, 2009
Atrial fibrillation following cardiac surgery: clinical features and preventative strategiesDiana Kaireviciute, Audrius Aidietis, Gregory Y H LipThrombosis and Haemostasis|August 25, 2023
Non-vitamin K Antagonist Oral Anticoagulant, Warfarin, and ABC Pathway Adherence on Hierarchical Outcomes: Win Ratio Analysis of the COOL-AF RegistrySukrit Treewaree, Gregory Y H Lip, Rungroj KrittayaphongCurrent Vascular Pharmacology|November 6, 2013
Inflammatory Biomarkers and Atrial Fibrillation: Potential Role of Inflammatory Pathways in the Pathogenesis of Atrial Fibrillation-induced ThromboembolismYutao Guo, Gregory Y H Lip, Stavros ApostolakisEbiomedicine|March 17, 2016
Emerging Tools for Stroke Prevention in Atrial FibrillationChristos Voukalis, Gregory Y H Lip, Eduard ShantsilaExpert Opinion on Emerging Drugs|March 17, 2023
A review of emerging factor XI inhibitorsSandra Elsheikh, Nicola Tidbury, Gregory Y H LipJournal of Thrombosis and Thrombolysis|May 25, 2025
Mon4 as a novel monocyte subset with distinct profile and predictor of poor outcomes in individuals with myocardial infarctionMaxime Boidin, Gregory Y H Lip, Eduard ShantsilaThrombosis Research|June 24, 2003
Fibrinolytic function and atrial fibrillationFrancisco Marín, Vanessa Roldán, Gregory Y H LipPageof 288